South Alabama Medical Science Foundation
Patent Owner
Stats
- 20 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Aug 11, 2016 most recent publication
Details
- 20 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 558 Total Citation Count
- Jun 26, 1980 Earliest Filing
- 29 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
7172778 Food and vitamin preparations containing the natural isomer of reduced folatesDec 30, 03Feb 06, 07[A23L]
6808725 Preparations containing folic acid and a natural isomer of a reduced folateJun 18, 02Oct 26, 04[A23L]
6673381 Uses for food and vitamin preparations containing the natural isomer of reduced folatesJul 16, 02Jan 06, 04[A23L]
6534060 Oncofetal antigen specific T-lymphocyte mediated immune response: manipulation and uses of oncofetal antigen specific CD4, CD8 cytotoxic and suppressor T cells and interleukin-10Oct 31, 00Mar 18, 03[A61K]
6451360 Method for treating a subject afflicted with intestinal malabsorptionJun 25, 01Sep 17, 02[A23L]
6335174 Oncofetal antigen specific t-lymphocyte mediated immune response: manipulation and uses of oncofetal antigen specific CD4, CD8 cytotoxic and suppressor T cells and interleukin-10Apr 04, 97Jan 01, 02[G01N]
6274615 Method for delaying the onset of alheimer's disease and for treatment or delaying the onset of other amyloidosis-related diseases/disordersMar 25, 99Aug 14, 01[A61K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0229,918 TUMOR SELECTIVE ANTIBODIES SPECIFIC TO ONCOFETAL ANTIGEN/IMMATURE LAMININ RECEPTOR PROTEINAbandonedJul 11, 14Aug 11, 16[G01N, C07K]
2015/0218,287 TUMOR SELECTIVE ANTIBODIES SPECIFIC TO ONCOFETAL ANTIGEN/IMMATURE LAMININ RECEPTOR PROTEINAbandonedFeb 04, 15Aug 06, 15[G01N, C07K]
8598134 RNAi modulation of RSV, PIV and other respiratory viruses and uses thereofExpiredJul 23, 10Dec 03, 13[C07H, C12N]
2013/0052,211 VACCINES WITH ONCOFETAL ANTIGEN/ILRP-LOADED AUTOLOGOUS DENDRITIC CELLS AND USES THEREOFAbandonedJul 09, 10Feb 28, 13[A61K, C12N, G01N, A61P]
7790878 RNAi modulation of RSV, PIV and other respiratory viruses and uses thereofExpiredJun 25, 09Sep 07, 10[C07H, A61K]
7674490 Food and vitamin preparations containing the natural isomer of reduced folatesExpiredFeb 03, 07Mar 09, 10[A23L]
2009/0310,601 COMMUNICATION CONTROL DEVICE, COMMUNICATION TERMINAL DEVICE, COMMUNICATION SYSTEM, AND COMMUNICATION CONTROL METHODAbandonedJun 11, 09Dec 17, 09[H04L]
7592322 RNAi modulation of RSV, PIV and other respiratory viruses and uses thereofExpiredJun 14, 05Sep 22, 09[A61K, C07H]
2006/0089,324 RNAi modulation of RSV, PIV and other respiratory viruses and uses thereofAbandonedJun 14, 05Apr 27, 06[A61K]
2005/0232,922 Oncofetal antigen specific T-lymphocyte mediated immune response: manipulation and uses of oncofetal antigen specific CD4, CD8 cytotoxic and suppressor T cells and interleukin-10AbandonedJun 03, 05Oct 20, 05[A61K]
6599742 Antisense oligonucleotide inhibition of human serine/threonine protein phosphatase gene expressionExpiredApr 03, 01Jul 29, 03[C07H, A61K, C12N]
2003/0124,125 Oncofetal antigen specific T-lymphocyte mediated immune response: manipulation and uses of oncofetal antigen specific CD4, CD8 cytotoxic and suppressor T cells and interleukin-10AbandonedNov 14, 02Jul 03, 03[A61K, C12N]
6562564 Decreasing cell proliferation by decreasing levels of PP5ExpiredAug 28, 00May 13, 03[C07H, C12Q, C07K]
6130207 Cell-specific molecule and method for importing DNA into a nucleusExpiredNov 05, 97Oct 10, 00[A61K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
